Endoscopic drainage of presumed resectable perihilar cholangiocarcinoma using a novel design short fully covered self-expanding metal stent with retrieval string (CHORDA)

Amsterdam UMC0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•18 years or older.
•- Capable of providing written and oral informed consent.
•- Presumed perihilar cholangiocarcinoma.
•- Biliary obstruction in the future liver remnant.
•- Drainage naïve patients: total bilirubin >50 umol/L
•- Patients with previous endobiliary drainage procedures: persistently rising total bilirubin >50 umol/L (i.e. no stent placed or insufficient draining stent) or persistent biliary dilatation in the future liver remnant on imaging (i.e. previous stent placed in contralateral side of the liver).

•- Incompletely recovered from any side effects of previous biliary drainage procedures. Patients are required to be off antibiotic treatment for at least 5 days.
•- Any contra-indication for major liver surgery (e.g. ECOG/WHO score 3 or higher).
•- Technical contra-indications for endobiliary drainage (e.g. previous gastrojejunostomy).
•- Refusal to provide informed consent.
•- Requirement of multiple stents for adequate drainage of the future liver remnant (e.g. involvement of segmental bile ducts).
•- In case it is not feasible to prevent blockage of one or more large segmental branches.

发起方

Amsterdam UMC